BAM vs LYG

The Advanced Deterministic Scorecard reveals a weak Piotroski F-Score of 3/9, indicating poor financial health, which raises concerns despite strong profitability and growth metrics. The absence of an Altman Z-Score prevents a full distress risk assessment, but the low Piotroski score suggests operational or balance sheet weaknesses. While the company exhibits robust ROE (22.57%), high margins, and strong earnings growth (34.3% YoY), these are offset by an elevated valuation (P/E 33.29, P/B 9.77) and a concerning 109.19% payout ratio that threatens dividend sustainability. Price performance has weakened recently, with a 1Y return of -9.3%, and insider sentiment is neutral, offering no catalysts.

LYG presents a stark contrast between explosive growth and deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock trades at a significant premium to its Graham Number ($2.80), it remains below its growth-based intrinsic value of $10.91. Massive YoY earnings growth (146.4%) and a healthy dividend payout provide a bullish catalyst, but these are offset by a bearish technical trend (0/100) and poor internal health metrics. The overall outlook is neutral as the growth trajectory battles fundamental instability.